Cite
HARVARD Citation
Kehoe, P. et al. (2021). Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet neurology. 20 (11), pp. 895-906. [Online].